The Latest Breaking News from Dolby Laboratories

Audio technology is evolving at a rapid pace with growing investments in cutting-edge technologies and innovations. Dolby Laboratories (DLB) stands at the forefront of the segment and is poised to benefit significantly. So, let’s analyze DLB to understand whether its a sound investment today. Read on to know more.

Dolby Laboratories (DLB) is a powerhouse of innovations and creativity that is powering the entertainment industry across the globe. The company is positioned for robust growth with its elaborate product offerings, recent acquisitions, strategic alliances, and solid financial performance. So, let's determine whether Dolby matches your portfolio rhythm. Read more…

Audio and video tech leader Dolby Laboratories showed progress in expanding its reach into new markets at the CES 2024 tech trade show this week.

Dolby delivered mixed results for its fiscal fourth quarter and offered a soft outlook for the current quarter and year ahead.

While Dolby Laboratories (DLB) is making strides to enhance offerings and elevate customer experience, the stock witnessed significant insider selling over the past year. So, will it be worth buying DLB? Read on.

Rising demand for advanced technological solutions worldwide is poised to keep the tech industry buoyed in the foreseeable future. Given this backdrop, quality tech stocks Dolby Laboratories (DLB), CTS Corporation (CTS), and Bel Fuse (BELFB), catching investors’ attention, could be solid buys now. Read on….

The electronics industry is riding high on the wings of technological innovation and advancements. As a result, it seems wise to invest in fundamentally sound electronics stocks Dolby Laboratories (DLB), Arrow Electronics (ARW), and EchoStar (SATS) that have the potential to harness the industry's growth and yield substantial returns. Read…

Today's chat bots aren't quite ready to replace the Geek Squad when it comes to knowing about the latest models, but one was better than the other.

Pulled from Benzinga Pro data, Dolby Laboratories (NYSE:DLB) posted Q2 earnings of $36.52 million, an increase from Q1 of 54.36%. Sales dropped to $334.37 million, a 4.91% decrease between quarters.